Pfizer Gets CDSCO Panel Nod To Study Anti-cancer Drug PF-07220060 Dr. Divya Colin9 Jan 2025 6:00 PM ISTNew Delhi: The drug major Pfizer has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
AstraZeneca Gets CDSCO Panel Nod To study Anti-Cancer Drug Rilvegostomig Dr. Divya Colin27 Dec 2024 6:00 PM ISTNew Delhi: Pharmaceutical major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Standard Control...
CDSCO Panel Approves GSK Protocol Amendment proposal for Belrestotug and Dostarlimab study Dr. Divya Colin27 Dec 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the drug major...
BDR Pharmaceuticals Gets CDSCO Panel Nod for bioequvalence study of Abiraterone Acetate Oral Suspension Dr. Divya Colin25 Dec 2024 6:15 PM ISTNew Delhi: BDR Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
MSD Pharmaceutical Gets CDSCO Panel Nod To study MK-1084 Dr. Divya Colin17 Dec 2024 6:00 PM ISTNew Delhi: MSD Pharmaceutical has got approval from the Subject Expert Committee SEC functional under the Central Drug Standard Control Organisation...
CDSCO panel approves AstraZeneca's Protocol Amendment proposal for Anticancer Drug AZD5305 study Dr. Divya Colin15 Dec 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Glenmark Pharmaceuticals Gets CDSCO Panel Nod To Import and Market anticancer Drug Zanubrutinib Capsules 80mg Dr. Divya Colin13 Dec 2024 6:00 PM ISTNew Delhi: Pharmaceutical major Glenmark Pharmaceuticals has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central...
Intas Pharmaceutical Gets CDSCO Panel Nod To Manufacture, Market Anti-cancer Drug Pertuzumab Dr. Divya Colin1 Dec 2024 5:45 PM ISTNew Delhi: Intas Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel approves Roche Products' Polatuzumab Vedotin for Injection 30mg per vial for Diffuse large B-cell lymphoma Dr. Divya Colin30 Nov 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved Roche's proposal...
CDSCO panel Approves AstraZeneca's Protocol Amendment proposal for Datopotamab Deruxtecan study Dr. Divya Colin7 Nov 2024 6:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved AstraZeneca's...
Submit preclinical data in animal and Phase I CT data: CDSCO Panel Tells IQVIA on Pembrolizumab study Dr. Divya Colin2 Nov 2024 6:00 PM ISTNew Delhi: After reviewing the Phase I/III clinical study protocol of the anti-cancer drug Pembrolizumab, the Subject Expert Committee (SEC)...
AstraZeneca Gets CDSCO Panels Nod to study anticancer drug AZD0901 Dr. Divya Colin29 Oct 2024 6:00 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
